Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 1 paper. Top paper: “BTK Inhibitors Versus Venetoclax as First‐ or Second‐Line Therapy in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Real‐World Evidence Study”.
Yi Han, Anna Teschemaker, Anthony R. Mato, Meghan C. Thompson, Lindsey E. Roeker